Search
Search Results
##search.searchResults.foundPlural##
-
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4195PDF: 1335HTML: 2025 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4653PDF: 1510HTML: 2230Untitled: 189Untitled: 204Untitled: 211Untitled: 195Untitled: 196 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2707PDF: 917HTML: 342Preferred Reviewers: 190 -
-
The diagnostic pitfalls of mucormycosis
831PDF: 690HTML: 231 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
1973PDF: 612HTML: 244 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2210PDF: 912HTML: 11106 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1687PDF: 1042HTML: 228 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1698PDF: 656HTML: 317 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1028PDF: 525HTML: 1676Figures: 148Fifures Sanz: 157tables Sanz: 163Untitled: 158 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1779PDF: 880HTML: 933Referring article: 719
1 - 20 of 20 items







